Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III (MISTIE III)

What is the purpose of this trial?

A phase III, randomized, case-controlled, open-label, 500-subject clinical trial of minimally invasive surgery plus rt-PA in the treatment of intracerebral hemorrhage (ICH).

Participation Guidelines

Ages: 18 - 80 years

Gender: Both

Johns Hopkins University

Dates: 07/09/2015 - 09/30/2018

Last Updated: 10/01/2015

Study HIC#: 1412015067

Get Involved

For more information about this study, contact:
Sara Jasak
+1 203-737-7629

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email or call 1-877-978-8348.

Trial Image


Lauren Sansing

Principal Investigator